Photobiomodulation Therapy for the Management of Breast Cancer-related Lymphedema

Launched by JESSA HOSPITAL · Dec 28, 2020

Keywords

ClinConnect Summary

This clinical trial is studying a treatment called Photobiomodulation Therapy (PBMT) to help manage lymphedema in women who have been treated for breast cancer. Lymphedema is a condition that can cause swelling, pain, and tightness in the arm after breast cancer treatment. PBMT uses special lights to improve healing and reduce pain and swelling. The goal of this study is to see how effective this light therapy is for women dealing with breast cancer-related lymphedema.

To participate in this trial, women must be at least 18 years old and have been diagnosed with breast cancer. They should have had surgery for breast cancer and have developed lymphedema that meets certain criteria. Participants will receive PBMT and will be monitored to see how it helps with their symptoms. This study is currently recruiting participants, so if you or someone you know is interested, it’s a good idea to talk to a healthcare provider for more information.

Gender

FEMALE

Eligibility criteria

• Inclusion Criteria:
• • Diagnosed with breast cancer
• • Underwent ipsilateral lumpectomy or mastectomy + sentinel lymph node biopsy +/- lymph node dissection
• • Underwent radiotherapy with or without chemotherapy
• • Diagnosed with BCRL (i.e. International Society of Lymphology (ISL) lymphedema stage I or higher)
• • Age ≥ 18 years
• • Able to comply to the study protocol
• • Able to sign written informed consent
• Exclusion Criteria:
• • Metastatic disease
• • Pregnancy
• • History of surgery or trauma to the arm
• • History of arm infection in the past 3 months
• • Use of medications that affect body fluid (e.g., diuretics) in the last 3 months
• • Severe psychological disorder or dementia
• • Any condition that is unstable or could affect the safety of the patient and their compliance in the study as judged by the investigator